Hebei Zhitong Bio Pharmaceutical

Hebei Zhitong Bio Pharmaceutical is a comprehensive pharmaceutical enterprise based in Dingzhou, Hebei Province, China, focusing on the research, production, and sale of biochemical and chemical medicines. The company's product portfolio primarily targets neurology, cardiovascular health, and immunology, with flagship products including cerebroprotein hydrolysate and thymopentin injections. Operating with multiple GMP-certified production lines, the firm integrates traditional pharmaceutical manufacturing with modern biotechnological processes. Zhitong Bio Pharmaceutical is recognized as a high-tech enterprise in China and maintains a significant presence in the domestic hospital supply chain. Its research initiatives are geared toward developing innovative formulations and improving the efficacy of existing biochemical treatments.